| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.09T | 1.08T | 1.02T | 1.00T | 888.67B | 806.63B |
| Gross Profit | 235.87B | 231.53B | 220.27B | 200.08B | 199.11B | 180.90B |
| EBITDA | 111.40B | 124.30B | 115.51B | 106.34B | 107.95B | 88.84B |
| Net Income | 50.44B | 49.08B | 44.36B | 40.14B | 43.21B | 27.37B |
Balance Sheet | ||||||
| Total Assets | 1.22T | 1.25T | 1.22T | 1.09T | 1.02T | 926.82B |
| Cash, Cash Equivalents and Short-Term Investments | 60.46B | 70.61B | 64.97B | 65.94B | 59.55B | 45.98B |
| Total Debt | 429.69B | 418.23B | 443.25B | 390.21B | 373.74B | 337.82B |
| Total Liabilities | 692.13B | 713.29B | 714.21B | 645.16B | 602.17B | 554.43B |
| Stockholders Equity | 513.66B | 517.14B | 488.56B | 430.23B | 395.13B | 357.80B |
Cash Flow | ||||||
| Free Cash Flow | 15.69B | 25.76B | 16.16B | -9.72B | 25.24B | 24.57B |
| Operating Cash Flow | 87.40B | 93.24B | 79.63B | 56.95B | 71.57B | 76.60B |
| Investing Cash Flow | -65.14B | -62.17B | -97.97B | -71.14B | -53.15B | -52.70B |
| Financing Cash Flow | -26.25B | -27.34B | 14.72B | 19.26B | -6.62B | -20.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $357.65B | 8.50 | 11.71% | 4.52% | 1.29% | -22.20% | |
| ― | $555.40B | 13.32 | 6.42% | 3.50% | -6.27% | 40.98% | |
| ― | $265.98B | 11.74 | 4.90% | 3.52% | 3.80% | -11.14% | |
| ― | ¥648.55B | 19.00 | 12.59% | 1.64% | 4.89% | -3.79% | |
| ― | $513.17B | 10.07 | 10.06% | 3.23% | 4.35% | 7.88% | |
| ― | $693.99B | 45.84 | 1.78% | 4.11% | -0.91% | -74.07% | |
| ― | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Air Water Inc. has announced the establishment of a Special Investigating Committee to address inappropriate accounting practices involving the deferral of loss recognition, impacting approximately 2.5 billion yen across four cases. The company is cooperating with the investigation and will provide updates to stakeholders as findings become available, while apologizing for the inconvenience caused.
The most recent analyst rating on (JP:4088) stock is a Buy with a Yen2806.00 price target. To see the full list of analyst forecasts on Air Water stock, see the JP:4088 Stock Forecast page.
Air Water Inc. has announced the establishment of a Special Investigating Committee following the discovery of inappropriate accounting practices at several of its subsidiaries. The committee, composed of external experts, will conduct a thorough investigation to assess the financial impact and recommend measures to prevent recurrence. This move aims to ensure transparency and restore stakeholder confidence amid concerns over the company’s financial reporting practices.
The most recent analyst rating on (JP:4088) stock is a Buy with a Yen2806.00 price target. To see the full list of analyst forecasts on Air Water stock, see the JP:4088 Stock Forecast page.
Air Water Inc. has successfully completed a tender offer for the common shares of Ci Medical Co., Ltd., which will become a consolidated subsidiary of Air Water as of October 14, 2025. This acquisition is expected to enhance Air Water’s operational capabilities and market positioning within the medical industry, potentially impacting stakeholders positively by expanding its portfolio and consolidating its presence in the market.
The most recent analyst rating on (JP:4088) stock is a Buy with a Yen2806.00 price target. To see the full list of analyst forecasts on Air Water stock, see the JP:4088 Stock Forecast page.
Air Water Inc. has announced an amendment to its tender offer for Ci Medical Co., Ltd., extending the offer period by 10 business days until October 6, 2025. This decision follows the Japan Fair Trade Commission’s notice that no exclusion order will be issued, allowing the tender offer to proceed without withdrawal, which could impact Air Water’s strategic positioning in the medical sector.
The most recent analyst rating on (JP:4088) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on Air Water stock, see the JP:4088 Stock Forecast page.
Air Water Inc. is a Japanese company operating in various sectors, including Digital & Industry, Energy Solutions, Health & Safety, Agriculture & Foods, and Other Businesses, with a focus on manufacturing and selling industrial gases, energy solutions, and health-related products.
Air Water Inc. has announced a tender offer to acquire all shares of Ci Medical Co., Ltd., aiming to privatize the company. The tender offer is supported by Ci Medical’s board and involves a significant agreement with its largest shareholder, Mr. Kiyoto Shimizu, to consolidate ownership and facilitate the acquisition process.
Air Water Inc. has announced a company split to transfer part of its industrial gas business to its subsidiary, Air Water Gas Products Inc., effective October 1, 2025. This move aims to streamline operations and strengthen the company’s position in the expanding electronics-related gas sector, while also focusing on global expansion.
Air Water Inc. has completed the payment procedures for the disposal of its treasury shares as restricted stock compensation, initially resolved by the Board of Directors on July 9, 2025. This move involves the disposal of 60,673 shares at a price of 2,191.5 yen per share, totaling 132,964,880 yen, and is aimed at compensating directors and executive officers, potentially impacting the company’s stock management and executive incentives.